Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies | |
Li, L; Li, SY; Deng, K; Liu, JL; Vandvik, PO; Zhao, PJ; Zhang, LH; Shen, JT; Bala, MM; Sohani, ZN | |
刊名 | BMJ-BRITISH MEDICAL JOURNAL |
2016-02-17 | |
卷号 | 352 |
ISSN号 | 1756-1833 |
通讯作者 | Sun, X (reprint author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610041, Sichuan, Peoples R China. |
学科主题 | General & Internal Medicine |
收录类别 | SCIE ; PUBMED ; MEDLINE ; ESI |
出版地 | LONDON |
语种 | 英语 |
WOS记录号 | WOS:000370727700007 |
内容类型 | 期刊论文 |
源URL | [http://ir.lzu.edu.cn/handle/262010/179421] |
专题 | 第二临床医学院_期刊论文 |
推荐引用方式 GB/T 7714 | Li, L,Li, SY,Deng, K,et al. Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies[J]. BMJ-BRITISH MEDICAL JOURNAL,2016,352. |
APA | Li, L.,Li, SY.,Deng, K.,Liu, JL.,Vandvik, PO.,...&Sun, X.(2016).Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.BMJ-BRITISH MEDICAL JOURNAL,352. |
MLA | Li, L,et al."Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies".BMJ-BRITISH MEDICAL JOURNAL 352(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论